Atrial fibrillation trials recruiting in New Jersey

All Atrial fibrillation trials nationally

Cities in New Jersey

Recruiting trials in New Jersey

• A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
  NCT06455098 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · New Jersey: Morristown
• A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
  NCT07217067 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Camden
• Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
  NCT04045665 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Neptune City
• Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
  NCT03907046 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Edison, Hackensack, Livingston, Neptune City
• Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)
  NCT07308847 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · New Jersey: Paramus
• ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3
  NCT06716021 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Haddon Heights
• Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
  NCT04088071 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Haddon Heights
• Renal Denervation + PVI vs PVI Alone for Persistent AF
  NCT05116384 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Short Hills
• Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
  NCT06735534 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Marlton
• Repeatable Evaluation of Functional Intra-procedural Signals for Effect in Pulsed Field Ablation REFINE-PFA
  NCT07275151 · Phase: Not specified · Ages: 21 Years and older · Sex: All (male and female) · New Jersey: Paramus
• Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
  NCT05712200 · Phase: Phase 3 · Ages: 65 Years and older · Sex: All (male and female) · New Jersey: Elmer, Englewood, Sewell, Somerset
• The Fourth Left Atrial Appendage Occlusion Study
  NCT05963698 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Hackensack
• The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
  NCT05836987 · Phase: Phase 3 · Ages: 22 Years to 85 Years · Sex: All (male and female) · New Jersey: Flemington, Hackensack, Piscataway, Ridgewood